• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Advanced analytics to identify risk of potentially inappropriate prescription opioid use

Bioengineer by Bioengineer
June 7, 2017
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: (UAHS BioCommunications)

New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.

Dr. Lo-Ciganic, assistant professor of pharmacy, has been awarded a $100,000, one-year Research Starter Grant for Health Outcomes from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. TheResearch Starter Award for Health Outcomes will allow her to apply advanced analytics to Medicare claims data (a 5 percent national representative sample with 3 million beneficiaries) from 2011 to 2015 to discover hidden patterns within complex health-care data. With this information, she will be able to generate precise prediction tools that can better guide health-care providers in implementing effective interventions and policies.

The advanced analytics used in this study are similar to "machine-learning approaches" used by companies such as Amazon and Netflix.

"Think of these companies that, based on your previous searches or purchases, can predict and promote items specifically for you. We are applying similar data-driven approaches to better predict inappropriate opioid use among Medicare beneficiaries," said Dr. Lo-Ciganic.

Dr. Lo-Ciganic added that traditional statistical methods have limited ability to handle missing values or complex interactions in health-care data.

"While prior studies have focused on identifying individual risk factors rather than predicting actual risk, they haven't taken into account complex interactions between opioid use and other factors such as substance use disorders, mental health disorders and frequent emergency department visits," Dr. Lo-Ciganic said. "Using advanced analytics, we can sort through massive amounts of complex data and develop tools to better predict patients who may need to be monitored or have interventions put into place."

Her study not only will identify and predict beneficiaries at risk for inappropriate prescription opioid use, it also will identify geographic "hot-spots," or clusters, of inappropriate opioid use. The findings from this study will allow health-care providers to better allocate resources for targeted interventions and help communities develop tailored care plans for specific at-risk regions or populations.

###

Dr. Lo-Ciganic is a pharmacoepidemiologist who has interests in medication adherence, drug safety, cancer prevention, quality and value of prescribing and application of innovative methods. Her newlyfunded research builds on previous research she completed as a postdoctoral associate for the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh Health Policy Institute.

About the UA College of Pharmacy

Established in 1947, the College of Pharmacy was the first health sciences college at the University of Arizona and is celebrating its 70th anniversary this year. Educating pharmacists and pharmaceutical scientists, the college participates in many interprofessional and multiinstitutional educational and research collaborations throughout Arizona and globally. It is ranked among the premier colleges of pharmacy in the United States and is often among the top 20 colleges of pharmacy in terms of external funding for research, including funding from the National Institutes of Health. For more information, visit pharmacy.arizona.edu

About the University of Arizona Health Sciences

The University of Arizona Health Sciences is the statewide leader in biomedical research and health professions training. The UA Health Sciences includes the UA Colleges of Medicine (Phoenix and Tucson), Nursing, Pharmacy and Mel and Enid Zuckerman College of Public Health, with main campus locations in Tucson and the growing Phoenix Biomedical Campus in downtown Phoenix. From these vantage points, the UA Health Sciences reaches across the state of Arizona and the greater Southwest to provide cutting-edge health education, research, patient care and community outreach services. A major economic engine, the UA Health Sciences employs almost 5,000 people, has nearly 1,000 faculty members and garners more than $126 million in research grants and contracts annually. For more information: uahs.arizona.edu.

Media Contact

Alli Benjamin
[email protected]
520-626-3389

http://uahs.arizona.edu/

Original Source

http://opa.ahsc.arizona.edu/newsroom/news/2017/ua-researcher-uses-advanced-analytics-identify-individuals-risk-potentially

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Building Bonds: Community Partnerships in Hospital Care

September 2, 2025

SUGT1 Boosts Serous Ovarian Cancer via FH Downregulation

September 2, 2025

Switching Insulin to Degludec/Liraglutide: Body Changes in Seniors

September 2, 2025

Experts Call on Medical Community to Address Global Arms Industry

September 2, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Building Bonds: Community Partnerships in Hospital Care

SUGT1 Boosts Serous Ovarian Cancer via FH Downregulation

Comparative Study: CNNs vs. ViTs in Mammography

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.